BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21306303)

  • 1. Regulation of VEGF, MMP-9 and metastasis by CXCR4 in a prostate cancer cell line.
    Wang Q; Diao X; Sun J; Chen Z
    Cell Biol Int; 2011 Sep; 35(9):897-904. PubMed ID: 21306303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathways.
    Feng Y; Hu J; Ma J; Feng K; Zhang X; Yang S; Wang W; Zhang J; Zhang Y
    Eur J Cancer; 2011 Oct; 47(15):2353-63. PubMed ID: 21680174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
    Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
    Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients.
    Ottaiano A; Franco R; Aiello Talamanca A; Liguori G; Tatangelo F; Delrio P; Nasti G; Barletta E; Facchini G; Daniele B; Di Blasi A; Napolitano M; Ieranò C; Calemma R; Leonardi E; Albino V; De Angelis V; Falanga M; Boccia V; Capuozzo M; Parisi V; Botti G; Castello G; Vincenzo Iaffaioli R; Scala S
    Clin Cancer Res; 2006 May; 12(9):2795-803. PubMed ID: 16675573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T; Wu Y; Helman JI; Wen Y; Wang C; Li L
    Mol Cancer Res; 2011 Feb; 9(2):161-72. PubMed ID: 21205837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo.
    Sun YX; Schneider A; Jung Y; Wang J; Dai J; Wang J; Cook K; Osman NI; Koh-Paige AJ; Shim H; Pienta KJ; Keller ET; McCauley LK; Taichman RS
    J Bone Miner Res; 2005 Feb; 20(2):318-29. PubMed ID: 15647826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo.
    Lapteva N; Yang AG; Sanders DE; Strube RW; Chen SY
    Cancer Gene Ther; 2005 Jan; 12(1):84-9. PubMed ID: 15472715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C; Jiang T; Zhu L; Liu J; Cao J; Huang KJ; Qiu ZJ
    Int J Oncol; 2011 Jun; 38(6):1637-44. PubMed ID: 21479358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of growth of pancreatic cancer cell and expression of vascular endothelial growth factor by gene silencing with RNA interference.
    Wang J; Shi YQ; Yi J; Ye S; Wang LM; Xu YP; He M; Kong XM
    J Dig Dis; 2008 Nov; 9(4):228-37. PubMed ID: 18959596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vector-based RNA interference against vascular endothelial growth factor-A significantly limits vascularization and growth of prostate cancer in vivo.
    Wannenes F; Ciafré SA; Niola F; Frajese G; Farace MG
    Cancer Gene Ther; 2005 Dec; 12(12):926-34. PubMed ID: 15956982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proliferation suppression and apoptosis of ovarian carcinoma cells induced by small interfering RNA against vascular endothelial growth factor.
    Zhou J; Gan N; Zhang W; Lu W; Xie X
    J Obstet Gynaecol Res; 2010 Apr; 36(2):232-8. PubMed ID: 20492371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Establishment of RNA interfering retrovirus vector targeting CXCR4 gene driven by human prostate-specific antigen promoter and its biological effects on prostate cancer cells].
    Du YF; Xing YF; Zeng FQ; Lu P; Liu XY; Xiao YJ
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):489-94. PubMed ID: 18069626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemokine CXCL12 and its receptor CXCR4 expression are associated with perineural invasion of prostate cancer.
    Zhang S; Qi L; Li M; Zhang D; Xu S; Wang N; Sun B
    J Exp Clin Cancer Res; 2008 Nov; 27(1):62. PubMed ID: 18983683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of matrix metalloproteinase-9 mRNA and vascular endothelial growth factor protein in gastric carcinoma and its relationship to its pathological features and prognosis.
    Yang Q; Ye ZY; Zhang JX; Tao HQ; Li SG; Zhao ZS
    Anat Rec (Hoboken); 2010 Dec; 293(12):2012-9. PubMed ID: 21089052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional expression of CXC chemokine recepter-4 mediates the secretion of matrix metalloproteinases from mouse hepatocarcinoma cell lines with different lymphatic metastasis ability.
    Chu H; Zhou H; Liu Y; Liu X; Hu Y; Zhang J
    Int J Biochem Cell Biol; 2007; 39(1):197-205. PubMed ID: 16973405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of matrix metalloproteinase-9 in stromal cell-derived factor-1/CXCR4 pathway of lung cancer metastasis.
    Tang CH; Tan TW; Fu WM; Yang RS
    Carcinogenesis; 2008 Jan; 29(1):35-43. PubMed ID: 17916907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.